AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 53 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,125,939 | +37.2% | 610,902 | +64.4% | 0.15% | +22.7% |
| Q1 2022 | $1,549,322 | -25.7% | 371,540 | -7.5% | 0.12% | -10.5% |
| Q4 2021 | $2,083,993 | -20.1% | 401,540 | +0.9% | 0.13% | -26.5% |
| Q3 2021 | $2,607,385 | -17.0% | 398,074 | -15.9% | 0.18% | -13.4% |
| Q2 2021 | $3,141,211 | +126.7% | 473,074 | +205.2% | 0.21% | +28.2% |
| Q4 2020 | $1,385,530 | -66.5% | 154,981 | -40.0% | 0.16% | -71.3% |
| Q2 2020 | $4,141,511 | +229.2% | 258,360 | +23.0% | 0.57% | +81.5% |
| Q1 2020 | $1,257,978 | – | 210,013 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
| TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
| Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
| HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
| DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
| Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
| Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
| MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
| Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |